D-0713-2022 Class II Terminated

Recalled by Morton Grove Pharmaceuticals, Inc. — Morton Grove, IL

FDA drug recall D-0713-2022 was initiated by Morton Grove Pharmaceuticals, Inc. on Feb 21, 2022 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product. The recall status is terminated (terminated Aug 6, 2024).

Recall details

Product Type
Drugs
Report Date
Mar 9, 2022
Initiation Date
Feb 21, 2022
Termination Date
Aug 6, 2024
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.

Reason for recall

Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot #s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0713-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0713-2022. Report a data issue: hello@regdatalab.com.